SeaStar Medical Holding Corp

ICU NASDAQ Healthcare & Biotech United States US81256L1044
2.90 $
1.81 %

SeaStar Medical Holding Corp develops advanced medical to improve the treatment of kidney diseases.

Performance & Momentum

6 Months 14.60 %
1 Year 77.20 %
3 Years 97.73 %
5 Years 99.88 %

Strategic Analysis

SeaStar Medical Holding Corp positions itself in the medical technology sector with a focus on devices that enhance treatments for kidney diseases. Its specialization in a highly technical healthcare segment aims to address specific medical needs that are still underrepresented.

Strengths
  • Clear technological niche in kidney treatments
  • Disruption potential in a rapidly growing medical sector
Weaknesses
  • Severely degraded long-term stock performance
  • Lack of positive momentum and fragile financial visibility
Momentum

Momentum is currently neutral to extremely weak, reflecting a lack of investor confidence and a persistent unfavorable stock evolution. This implies a high risk in the short to medium term with few visible positive catalysts.

Similar stocks to SeaStar Medical Holding Corp

Anantys Community

Be the first to share your analysis on SeaStar Medical Holding Corp.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases